MounjaroMilpitas, CA

Mounjaro in Milpitas, CA

For Milpitas, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month uniformly, shipped directly to your Milpitas address.

FDA-approved Mounjaro prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Milpitas is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Mounjaro in Milpitas, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Mounjaro to patients in Milpitas from $329/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Mounjaro® by Eli Lilly is the FDA-approved Injectable pen Tirzepatide product, taken Once weekly and approved in 2022 for Type 2 diabetes. Tirzepatide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Milpitas residents: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month and includes the provider evaluation, the medication, ongoing care, and home delivery.

What treatment options are available locally?

Milpitas is home to a large and vibrant Hispanic community, and Weight Method is committed to providing culturally competent care. Our bilingual providers understand the dietary traditions, family dynamics, and health concerns common in Hispanic households — and they deliver consultations in English or Spanish. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. Tirzepatide does not require abandoning cultural foodways; it works by reducing appetite so you naturally eat smaller portions of the foods you love.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly. Weight Method prescribes compounded Tirzepatide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Tirzepatide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Tirzepatide is an appropriate option based on your medical history.

Yes. Weight Method's licensed providers in California can prescribe compounded Tirzepatide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Tirzepatide is shipped directly to your Milpitas address. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $329/month.

Mounjaro® is a Injectable pen manufactured by Eli Lilly, FDA-approved since 2022 for Type 2 diabetes. It contains Tirzepatide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Mounjaro® is taken Once weekly. Weight Method does not sell Mounjaro®; we are a separate program that prescribes compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $329/month.

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Tirzepatide program starts at $329/month and covers your medication, provider consultations, and free delivery to Milpitas. No insurance claims, no prior authorizations, and no surprise bills. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

The most common side effects of Tirzepatide are gastrointestinal — mild nausea, decreased appetite, and occasional digestive discomfort. These typically occur during the first few weeks or after dose increases and diminish as your body adjusts. Your Weight Method provider follows a gradual dose-escalation protocol designed to reduce side effects and will monitor your progress throughout treatment. Discuss your full medical history with your provider before starting any GLP-1 therapy.

Start Your Treatment

Consult with a licensed provider in California and start Mounjaro from $329/month.

Get Started Now

Free consultation. No commitment.

Other Brands in Milpitas

Ozempic in MilpitasWegovy in MilpitasZepbound in MilpitasRybelsus in MilpitasTirzepatide in Milpitas

Nearby Cities

Mounjaro in San Jose, CAMounjaro in Santa Clara, CAMounjaro in Mountain View, CAMounjaro in Sunnyvale, CA

See More

All About MounjaroTirzepatide in MilpitasClinics in Milpitas